Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative

Published:2024-02-14 Issue:5 Volume:59 Page:553-560
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Hammoudi Nassim¹²,Hassid Déborah²,Bonnet Joëlle¹²,Tran Minh My-Linh²,Baudry Clotilde²,Vauthier Anne²,Chedouba Leila¹²,Houzé Pascal³⁴,Lourenco Nelson²,Aparicio Thomas¹²,Gornet Jean-Marc²,Allez Matthieu¹²

Affiliation:

1. INSERM U1160, EMiLy, Institut de Recherche Saint-Louis, Université de Paris Cité, Paris, France

2. Gastroenterology Department, AP-HP, Hôpital Saint-Louis/Lariboisière, Paris, France

3. Laboratory of Toxicology, Federation of Toxicology, Lariboisière Hospital, Paris, France

4. INSERM UMRS-1144, University of Paris, Paris, France

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2024.2316765

Reference36 articles.

1. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

2. Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

3. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

4. On the definition of a criterion of immunogenicity

5. Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP